Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)

NCT07215403 is registered in ClinicalTrials.gov with AskBio Inc as lead sponsor.

NCT NCT07215403
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07215403 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label, Multi-Stage Study to Optimize the Intraputaminal Administration of AB-1005 Using a Prescriptive Infusion Algorithm (PIA)
Lead sponsor
AskBio Inc
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 30, 2026
Completion date
November 1, 2028
Enrollment
18 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease (disorder)